Gabrielle Jongeneel
0000-0001-9462-2246
5 papers found
Refreshing results…
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: a prospective cohort study
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
Model-based evaluation of the cost effectiveness of 3versus6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data
Missing publications? Search for publications with a matching author name.